Prognostic Model for Predicting Survival in Men With Hormone-Refractory Metastatic Prostate CancerSusan Halabi, Nicholas J. Vogelzang, Ellis Levine et al.|Journal of Clinical Oncology|2003Cited by 678
Antiandrogen Withdrawal Alone or in Combination With Ketoconazole in Androgen-Independent Prostate Cancer Patients: A Phase III Trial (CALGB 9583)Eric J. Small, Nicholas J. Vogelzang, Preston Gable et al.|Journal of Clinical Oncology|2004Cited by 502